𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MicroRNAs are novel biomarkers of colorectal cancer

✍ Scribed by M. I. Aslam; K. Taylor; J. H. Pringle; J. S. Jameson

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
183 KB
Volume
96
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

Recent studies have identified unique small ribonucleic acids called microRNAs (miRNAs) in colonic tumour tissue and blood that may accurately diagnose the presence of colorectal cancer and help predict disease recurrence. This review explores the potential role of these biomarkers.

Methods

A literature search identified studies describing miRNAs in colorectal cancers. The outcomes of interest included diagnosis, progression and recurrence of disease, and future therapy.

Results

Overexpression and silencing of specific miRNAs are associated with the development and progression of colorectal cancer. Such a role in oncogenesis suggest that miRNAs may be important targets for gene therapies. Differential expression of specific miRNAs in tissues and blood offers the prospect of their use in early detection and screening for colorectal cancer. MiRNAs are implicated in metastasis and cytotoxic drug resistance. Their manipulation has potential in both prevention of recurrence and palliation.

Conclusion

The miRNAs expression profile in tissue and blood has potential for their use in the detection, screening and surveillance of colorectal cancer. Furthermore, miRNAs may be targeted by gene therapy to treat colorectal cancer.

πŸ“œ SIMILAR VOLUMES

Oncogenic microRNAs (OncomiRs) as a new
Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers
✍ Vladimir A. Krutovskikh; Zdenko Herceg πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 224 KB πŸ‘ 1 views

## Abstract Small non‐coding RNAs (microRNAs or miRs) represent one of the most fertile areas of cancer research and recent advances in the field have prompted us to reconsider the traditional concept of cancer. Some miRs exert negative control over the expression of numerous oncoproteins in normal

Potential roles of genetic biomarkers in
Potential roles of genetic biomarkers in colorectal cancer chemoprevention
✍ Sapna Syngal; Gerard Clarke; Prathap Bandipalliam πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 2 views

Colorectal cancer is a significant cause of morbidity and mortality in industrialized societies and the second most frequent cause of cancer death in the United States. Surrogate endpoint biomarkers are gaining wide acceptance in early diagnosis and short-term cancer chemoprevention trials in place

Semiparametric estimation for joint mode
Semiparametric estimation for joint modeling of colorectal cancer risk and functional biomarkers measured with errors
✍ Qi Long; Xiaoxi Zhang; Roberd M. Bostick πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 292 KB πŸ‘ 2 views

This research is motivated by a pilot colorectal adenoma study, where the outcome of interest is the presence of colorectal adenoma representing risk for colorectal cancer, and the predictors of interest are protein biomarkers that are repeatedly measured with errors along the length of a microscopi

Conserved region mutations of the p53 ge
Conserved region mutations of the p53 gene are concentrated in distal colorectal cancers
✍ Petra Jernvall; Markus MΓ€kinen; Tuomo Karttunen; Jyrki MΓ€kelΓ€; Pirkko Vihko πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 247 KB πŸ‘ 2 views

Distal colorectal cancers, especially those in the rectum, are more aggressive and more commonly recurrent than proximal cancers. We studied the possible relationship between p53-gene mutation type and location of the tumour, since mutations in the conserved areas of the p53 gene have been suggested